Sawai Group Holdings (4887) · InitiativeFirst statedLatest Earnings (2026-08-10): "Advanced"
Collaboration with Nichi-Iko Pharmaceutical to Consolidate Generic Pharmaceutical Products
First written in FY2026-H1. 1 of 2 entries say "Advanced", first in 2026-08-10. Latest entry: 2026-08-10.
2entries
2years
1from disclosures
How it moved
Same theme, other companies
Quality, Cost Competitiveness and Process Development for Generic PharmaceuticalsA theme 7 companies write about · 0 as a headwind · 8 as a tailwind
3 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- 2026-08-10AdvancedEarnings
「In addition, in September 2025 we agreed to collaborate with 日医工株式会社 on the integration of generic drug products and related matters, and in June 2026 obtained approval for the first expedited review of a specified manufacturing-process change under the collaboration.」
The collaboration with 日医工 progressed to the approval of the first expedited review of a specified manufacturing-process change. - FY2026-H1First statedAnnual report
「さらに、2025年９月には日医工株式会社と後発医薬品の品目統合等に向けた協業に合意し、後発医薬品業界全体の安定供給体制構築に努めております。」
2025年9月、日医工株式会社との後発医薬品の品目統合等に向けた協業合意を、業界全体の安定供給体制構築に向けた新たな取り組みとして記載した。